InflaRx Analyst Ratings

BenzingaDec 20 23:57 · Ratings

InflaRx Announces First Patient Dosed in Phase 2a Study for Oral C5aR Inhibitor INF904

GlobeNewswireDec 20 20:30

Is InflaRx N.V. (IFRX) the Best German Stock to Buy Now?

Yahoo FinanceNov 20 07:29

InflaRx Says Severe Covid Drug Gets EU Panel's Positive Opinion; Shares Rise Pre-Bell

MT NewswiresNov 15 21:42

InflaRx Gets EMA Nod for COVID-19 Treatment

TipRanksNov 15 21:30

InflaRx Shares Rise 12% After Regulators Favor Authorization of Gohibic

WSJNov 15 21:30